Physician profile
Kevin Ro
NPI 1477972628
$512.69
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.15 · 2020: $44.08 · 2021: $196 · 2022: $167 · 2023: $50.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $80.78 | 2021-2022 | |
| Radius Health, INC. | $50.47 | 2020-2022 | |
| Abbvie INC. | $44.24 | 2021-2022 | |
| Novo Nordisk INC | $37.03 | 2021 | |
| Corcept Therapeutics | $36.95 | 2023 | Korlym |
| Regeneron Healthcare Solutions, INC. | $35.55 | 2019-2022 | |
| Amgen INC. | $34.39 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $25.79 | 2021 | |
| Insulet Corporation | $25.38 | 2022 | |
| Amarin Pharma, INC. | $23.12 | 2019 | |
| Mannkind Corporation | $20.87 | 2022 | |
| Dexcom, INC. | $18.75 | 2021 | |
| Esperion Therapeutics, INC. | $18.34 | 2021 | |
| Medtronic Minimed, INC. | $16.93 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.80 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.71 | 2022 | |
| Tolmar, INC. | $13.59 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Ro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.